Stock VHI VITALHUB CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Vitalhub Corp.

Equities

VHI

CA92847V5018

Market Closed - Toronto S.E.
Other stock markets
 01:29:59 03/05/2024 am IST 		5-day change 1st Jan Change
6.49 CAD +1.88% Intraday chart for Vitalhub Corp. +6.39% +59.07%
01/05 VitalHub Appoints Patrick Mazza as COO, Niels Tofting as Managing Director of North American Operations MT
01/05 VitalHub Brief: Promoting Patrick Mazza to Chief Operating Officer and Niels Tofting to Executive Vice President, Managing Director of North American Operations MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 36.75 times its estimated earnings per share for the ongoing year.
  • With an enterprise value anticipated at 4.03 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
VITALHUB CORP. Stock Vitalhub Corp.
+59.07% 235M -
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.63% 32.15B
C
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+16.98% 7.41B
C-
SECTRA AB Stock Sectra AB
+20.94% 3.85B
B-
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-17.01% 3.13B
C-
OMNICELL, INC. Stock Omnicell, Inc.
-22.16% 1.25B
B
LUNIT INC. Stock Lunit Inc.
-31.01% 1.17B -
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+4.40% 926M
C
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-34.81% 911M -
VERADIGM INC. Stock Veradigm Inc.
-25.64% 842M -
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. VHI Stock
  4. Ratings Vitalhub Corp.